Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management
Shai Shimony, Maximilian Stahl, Richard M. Stone
American Journal of Hematology (2023) Vol. 98, Iss. 3, pp. 502-526
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
Anna Candoni, Gabriele Coppola
Hematology Reports (2024) Vol. 16, Iss. 2, pp. 244-254
Open Access | Times Cited: 21
Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology
Muhammad Hossein Ashoub, Razieh Razavi, Kamran Heydaryan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients
Naseema Gangat, Omer Karrar, Moazah Iftikhar, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 2, pp. 193-202
Open Access | Times Cited: 35
Comparative Analysis of Reverse Degree and Entropy Topological Indices for Drug Molecules in Blood Cancer Treatment through QSPR Regression Models
Micheal Arockiaraj, A. Berin Greeni, A. R. Abul Kalaam
Polycyclic aromatic compounds (2023), pp. 1-18
Closed Access | Times Cited: 27
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm
Elvira Pelosi, Germana Castelli, Ugo Testa
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2718-2718
Open Access | Times Cited: 22
Global, national, and regional burden of acute myeloid leukemia among 60–89 years-old individuals: insights from a study covering the period 1990 to 2019
Pengyin Chen, Xinling Liu, Yao Zhao, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 10
Cellular automata modelling of leukaemic stem cell dynamics in acute myeloid leukaemia: insights into predictive outcomes and targeted therapies
Yutaka Saikawa, Toshihiko KOMATSUZAKI, Nobuaki Nishiyama, et al.
Royal Society Open Science (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity and overcomes resistance in acute myeloid leukemia
Yujun Chen, Yu Zhao, Mingyue Yao, et al.
Acta Pharmacologica Sinica (2025)
Open Access | Times Cited: 1
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival
Omer Karrar, Maymona Abdelmagid, Masooma S Rana, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 2
Open Access | Times Cited: 16
p53 biology and reactivation for improved therapy in MDS and AML
Joanna Zawacka‐Pankau
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Targeting a lineage-specific PI3Kɣ–Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule
Loïs Kelly, Justine C. Rutter, Kevin Lin, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 1082-1101
Closed Access | Times Cited: 7
N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2
Diguang Wen, Hang Xiao, Yueyi Gao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Current knowledge about FLT3 gene mutations, exploring the isoforms, and protein importance in AML
Diana Macečková, Lenka Vaňková, Monika Holubová, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 6
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
Matthew J. Frigault, Charlotte Graham, Trisha R. Berger, et al.
Blood (2024) Vol. 144, Iss. 11, pp. 1153-1167
Closed Access | Times Cited: 5
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL
Karin Bauer, Alexander W. Hauswirth, Karoline V. Gleixner, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 9, pp. 1721-1731
Open Access | Times Cited: 5
Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation
Ruirui Kou, Tian Li, Caizhu Fu, et al.
Environmental Research (2023) Vol. 244, pp. 117783-117783
Closed Access | Times Cited: 15
Holotrichones A and B, potent anti-leukemic lindenane-type sesquiterpene trimers with unprecedented complex carbon skeletons from a rare Chloranthus species
Xuejiao Wang, Jun-Li Xin, Hong Xiang, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 12, pp. 109682-109682
Closed Access | Times Cited: 5
Multiple machine-learning tools identifying prognostic biomarkers for acute Myeloid Leukemia
Yujing Cheng, Xin Yang, Ying Wang, et al.
BMC Medical Informatics and Decision Making (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia
Wingchi K. Leung, Alejandro G. Torres Chavez, Matthew French-Kim, et al.
Blood (2024) Vol. 143, Iss. 17, pp. 1726-1737
Closed Access | Times Cited: 4
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells
Yi Zhang, Miso Park, Lucy Ghoda, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Construction of a stromal-related prognostic model in acute myeloid leukemia by comprehensive bioinformatics analysis
Laya Khodayi Hajipirloo, Maryam Nabigol, Reza Khayami, et al.
Current Research in Translational Medicine (2025) Vol. 73, Iss. 2, pp. 103492-103492
Closed Access
Differential expression and pathological implications of Linc01089 and Linc01578 in acute myeloid leukemia
Zahra Khosroabadi, Mohammadreza Sharifi, Mansour Salehi, et al.
Gene Reports (2025) Vol. 38, pp. 102129-102129
Closed Access
Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies
Fei Fei, Milhan Telatar, Vanina Tomasian, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 435-435
Open Access
Advances of signal transducer and activator of transcription 3 inhibitors in acute myeloid leukemia (Review)
Hui Cheng, Li Chen, Chongmei Huang
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access
Page 1 - Next Page

Scroll to top